R
Rein Therapeutics Inc. (RNTX)
NCM – Real Time Price. Currency in USD
1.12
-0.03 (-2.61%)
At close: May 12, 2026, 4:00 PM EDT
1.11
-0.01 (-0.89%)
Pre-market: May 13, 2026, 8:47 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.12
-0.03 (-2.61%)
At close: May 12, 2026, 4:00 PM EDT
1.11
-0.01 (-0.89%)
Pre-market: May 13, 2026, 8:47 AM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Cash reserves $3.2M barely cover the upcoming debt maturities $0.0
Total current liabilities $6.2M surpass Total current assets $4.3M, signaling liquidity issues
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$3.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.70 | 6.05 | 4.0 | |
| Quick ratio | 0.70 | 5.63 | 4.0 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 5.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -169K | -119K | -63K | -1K | -1K |
| Operating Income | -28M | -15M | -28M | -22M | -22M |
| Net Income | -27M | -16M | -63M | -50M | -50M |
| EBITDA | -27M | -15M | -28M | -22M | -22M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -96 | 1.0 |
| Next quarter | N/A | -75 | 1.0 |
| Current year | N/A | 16.84 | 5.0 |
| Next year | N/A | 18.4 | 5.0 |
| Weighted average score | 3.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -472.77 | -419.04 | 9.24 | 4.5 |
| Y/Y | 999 | 22 | 42.33 | 33.08 | 10 |
| 3y average | 999 | -78.85 | 20.77 | 6.98 | 6.5 |
| 5y average | 999 | -52.93 | 31.33 | 0.05 | 5.8 |
| Weighted average score | 6.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |